ABDALLAH ALABADLA REMEMBERS THE NIGHT HE thought he was going to die. The college student had fled his home in Gaza City for Khan Younis, a place he thought would be safer. But soon after arriving, he found the city emptied of critical medical supplies.
"I went to every pharmacy in the area where I was staying, desperately looking for insulin," he said in a phone interview from Cairo, where he evacuated in March. "I thought I was going to die because I didn't find it. I don't know how to describe it. It was a horrible moment."
Alabadla, 23, was in his final semester at Al-Aqsa University, where he studied English literature before the October 7 attacks on Israel by Hamas and subsequent Israeli invasion of Gaza. He also has Type 1 diabetes and relies on taking insulin daily to stay alive.
Before the launch of Israel's offensive seeking to release the Israeli hostages and destroy Hamas, United Nations bodies estimated that up to 71,000 Palestinians in Gaza were living with diabetes as of November 2023. It is not known now how many of them have since fled or been killed.
Insulin is one of the medicines in "acute shortage" in Gaza, according to the World Health Organization, recalling a time before the advent of insulin therapy, when having diabetes-today considered a treatable condition almost always meant a death sentence within a matter of days or weeks.
Alabadla and others say they have gone to extreme measures to survive the shortage. They now frequently switch between multiple types of insulin based on availability rather than what is recommended for their unique needs, use expired insulin or resort to insulin rationing-a potentially fatal practice.
Dr. Waseem Alzaanin is a physician in Deir al-Balah, in central Gaza. Like Alabadla, he has Type 1 diabetes.
Esta historia es de la edición August 02 - 09, 2024 (Double Issue) de Newsweek US.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición August 02 - 09, 2024 (Double Issue) de Newsweek US.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Terry Crews
FOR TERRY CREWS, THERE ARE NO RULES.
Carrie Coon
CARRIE COON IS HAVING A MOMENT, EVEN THOUGH YOU MAY NOT RECognize her.
Still Doin' It Well
Ahead of the release of his new album, The FORCE, LL Cool J told Newsweek of his strong desire to keep contributing to the hip-hop culture he helped create
WORLD'S MOST TRUSTWORTHY COMPANIES 2024
TRUST IS AN ESSENTIAL PART OF ANY RELATIONSHIP-FROM PERsonal relationships to ties between businesses and consumers.
HOPE and HEALING on HORSEBACK
IT'S BEEN A DECADE SINCE ISIS COMMITTED GENOCIDE AGAINST IRAQ'S YAZIDI POPULATION. MORE THAN 100,000 YAZIDIS REMAIN DISPLACED BUT WORKERS AND ANIMALS AT AN EQUINE THERAPY CENTER ARE PROVIDING RELIEF
Is College Worth It?
AMERICANS are LOSING FAITH in HIGHER EDUCATION amid RISING TUITION FEES, UNCERTAIN PAYOFF and CULTURE WARS on CAMPUS
An integrated model for water management
Alkhorayef Water and Power Technologies has deep expertise and synergistic capabilities across the full water and wastewater value chain
Investments that are transforming life in Saudi Arabia
Abdullah Al Othaim Investment Company is creating distinctive destinations and experiences that encompass multiple sectors
A Kinder and Gentler Nick Cave
After a period of personal upheaval, the famed Bad Seeds singer returns with the vibrant and optimistic 'Wild God'
Fleeing War and Scams
Newsweek spoke to three Ukrainians who have been targeted by \"sponsors\" trying to profit from applicants seeking refuge in the U.S. via a humanitarian scheme